Immunovant, Inc. (IMVT)
NASDAQ·Healthcare·Biotechnology
$27.39
-4.30%
Mkt Cap $6.00B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 6, 2026 | $6.00M | — | — | -$0.72 | -$0.61 | +15.28% | — | — |
| Q4 2025 Nov 10, 2025 | — | — | — | -$0.72 | -$0.73 | -1.39% | — | — |
| Q3 2025 Aug 11, 2025 | — | — | — | -$0.69 | -$0.60 | +13.04% | — | — |
| Q2 2025 May 29, 2025 | — | — | — | -$0.71 | -$0.64 | +10.27% | — | — |
| Q1 2025 Feb 6, 2025 | — | — | — | -$0.73 | -$0.76 | -4.11% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.60 | -$0.74 | -23.33% | — | — |
| Q3 2024 Aug 6, 2024 | — | — | — | -$0.53 | -$0.60 | -13.21% | — | — |
| Q2 2024 May 29, 2024 | — | — | — | -$0.43 | -$0.52 | -20.93% | — | — |
| Q1 2024 Feb 12, 2024 | — | — | — | -$0.43 | -$0.36 | +16.28% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.47 | -$0.45 | +4.26% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.45 | -$0.57 | -26.67% | — | — |
| Q2 2023 May 22, 2023 | — | — | — | -$0.43 | -$0.46 | -6.98% | — | — |
| Q1 2023 Feb 3, 2023 | — | — | — | -$0.39 | -$0.49 | -25.64% | — | — |
| Q4 2022 Nov 4, 2022 | — | — | — | -$0.39 | -$0.41 | -5.13% | — | — |
| Q3 2022 Aug 5, 2022 | — | — | — | -$0.40 | -$0.35 | +12.50% | — | — |
| Q2 2022 Jun 8, 2022 | — | — | — | -$0.38 | -$0.41 | -7.89% | — | — |
| Q1 2022 Feb 4, 2022 | — | — | — | -$0.33 | -$0.36 | -9.09% | — | — |
| Q4 2021 Nov 5, 2021 | — | — | — | -$0.28 | -$0.35 | -25.00% | — | — |
| Q3 2021 Aug 9, 2021 | — | — | — | -$0.31 | -$0.31 | +0.00% | — | — |
| Q2 2021 Jun 1, 2021 | — | — | — | -$0.33 | -$0.29 | +12.12% | — | — |